300
Participants
Start Date
April 30, 2007
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
DYME
2ml of 0.25 mg/ml BBG 250 in sterile ophthalmic solution
DYME
2ml of 0.05 mg/ml BBG 250 in sterile ophthalmic solution
Island Eye Surgicenter, Carle Place
Eye Care Specialists, Kingston
Wills Eye Surgery Center, Philadelphia
Wills Surgery Center, Philadelphia
Center for Excellence in Eye Care, Miami
The Eye Institute of West Florida, Largo
The Ohio State University Hospital, Columbus
Eye Surgeons of Indiana, Indianapolis
SMDV Surgery Center, Madison
Ballas Surgery Center, St Louis
Silverstein Eye Centers, Kansas City
St. John's Clinic Eye Specialists, Springfield
McDonald Eye Associates, Fayetteville
Peace Laser Eye Center, Inglewood
Capitol City Surgery Center, Sacramento
Narayana Nethralaya, Bangalore
Bhagwan Mahaveer Jain Hospital, Bangalore
Narayana Nethralaya, Bangalore
Wills Eye Surgery Center, Cherry Hill
Brar-Parekh Eye Associates, Woodland Park
The Mehta International Eye Institute & Colaba Eye Hospital, Mumbai
Bombay City Eye Institute & Research Centre, Mumbai
Lead Sponsor
Aqumen Biopharmaceuticals, N.A.
INDUSTRY